Cargando…
MON-187 Prevalence and Assessment of Overnight Dexamethasone Suppression Tests for Screening Endogenous Hypercortisolism When Serum Dexamethasone Is Below Threshold
Background: The 1mg-dexamethasone (DXA) suppression test (DST) is used to verify cortisol (F) autonomy in Cushing’s syndrome (CS) and subclinical hypercortisolism (SCH) of adrenal incidentalomas (AI), based on the ability of DXA to suppress F by inhibiting the HPA axis. A post-DST serum F >1.8 μg...
Autores principales: | Farinelli, Denise Genaro, Kater, Claudio E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208616/ http://dx.doi.org/10.1210/jendso/bvaa046.1768 |
Ejemplares similares
-
SAT-372 Correlation of Serum Dexamethasone and Cortisol Concentrations Post Dexamethasone 1 Mg in the Overnight Dexamethasone Suppression Test in Patients with Unilateral and Bilateral Adrenal Incidentalomas
por: Naseem, Asma, et al.
Publicado: (2019) -
PSAT012 Endogenous Hypercortisolism Concealing an Autoimmune Disease
por: Dau, Jonathan, et al.
Publicado: (2022) -
MON-169 Diagnostic Utility of Free Cortisol in Dexamethasone Suppression Test. A Prospective Study in Healthy Subjects
por: Athimulam, Shobana, et al.
Publicado: (2020) -
SAT-369 Proposal of Optimal Cutoff value for Serum Cortisol after an Overnight 1-mg Dexamethasone Suppression Test - Results from Multicenter Collaborative Research in Japan.
por: Tanabe, Makito, et al.
Publicado: (2019) -
MON-165 Utility of Salivary Cortisol After 1 Mg Oral Dexamethasone in the Evaluation of Incidental Adrenal Tumors
por: Arregger, Alejandro L, et al.
Publicado: (2020)